TrialArthritis research & therapy2019

An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis.

Stanley Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.